Atlas Trials

A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

Clinical trial NCT07660848 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07660848
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Start date
2026-07-01
Primary completion
2028-03-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.